# Pharmaceutics International, Inc., Cockeysville, MD – FDA Inspections Source: https://www.keypedia.com/companies/pharmaceutics-international-inc/38fdf7bd-a7f3-486e-b74d-13b87414922e > Inspection records and compliance data for Pharmaceutics International, Inc. in Cockeysville, Maryland. 11 FDA inspections on record (2 OAI), 3 Form 483s, last inspected March 06, 2026. --- ## Details - Name: Pharmaceutics International, Inc. - FEI Number: 3006503102 - Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE - Address Line 1: 103 Beaver Ct - City: Cockeysville - State: Maryland - Zip Code: 21030 - Country Name: United States - Address: 103 Beaver Ct, Cockeysville, Maryland 21030, United States - Country: United States ## Related Documents - [FDA Inspection 1307080 - Pharmaceutics International, Inc. - 2026-03-06](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/357b9f0b-0f0d-44ec-abbf-4c4b6f1cde63) — source: FDA, date: March 6, 2026 - FDA Inspection 1244595 - Pharmaceutics International, Inc. - 2024-06-12 — classification: No Action Indicated (NAI), source: FDA, date: June 12, 2024 - [483 - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/483/pharmaceutics-international-inc/937931f6-45c4-44ee-8b03-39ff1917c695) — source: FDA, date: November 14, 2022 - [EIR - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/ef206f73-a4e1-444d-aae9-d09577c023c9) — source: FDA, date: November 14, 2022 - [FDA Inspection 1194409 - Pharmaceutics International, Inc. - 2022-11-14](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/c233b238-eb27-4d58-99dc-abe21668f706) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 14, 2022 - [EIR - Pharmaceutics International, Inc. - 2021-09-29](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/6073937e-d251-478b-9d02-6fc098e85b25) — source: FDA, date: September 29, 2021 - [483 - Pharmaceutics International, Inc. - 2021-09-29](https://www.keypedia.com/records/483/pharmaceutics-international-inc/98c0fefd-6d0c-4a86-ac7d-593085f5d47e) — source: FDA, date: September 29, 2021 - FDA Inspection 1155191 - Pharmaceutics International, Inc. - 2021-09-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2021 - [483 - Pharmaceutics International, Inc. - 2020-10-30](https://www.keypedia.com/records/483/pharmaceutics-international-inc/b1b883c2-e23c-45a1-9762-e36d6a7222af) — source: FDA, date: October 30, 2020 - [EIR - Pharmaceutics International, Inc. - 2020-07-10](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/ff6926d1-b00a-402d-8253-8e5e18aad5bc) — source: FDA, date: July 10, 2020 - [483 - Pharmaceutics International, Inc. - 2020-07-10](https://www.keypedia.com/records/483/pharmaceutics-international-inc/1f4d0f6f-9d88-4271-9537-82cbb1c04111) — source: FDA, date: July 10, 2020 - FDA Inspection 1124545 - Pharmaceutics International, Inc. - 2020-07-10 — classification: No Action Indicated (NAI), source: FDA, date: July 10, 2020 - [EIR - Pharmaceutics International, Inc. - 2018-11-09](https://www.keypedia.com/records/eir/pharmaceutics-international-inc/d380df3c-197b-499a-b180-1cdd078bcf5e) — source: FDA, date: November 9, 2018 - FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018 - FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09 — classification: No Action Indicated (NAI), source: FDA, date: November 9, 2018 - FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018 - [FDA Inspection 1072073 - Pharmaceutics International, Inc. - 2018-11-09](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/f3ba1bae-6f2d-49d8-ad30-c59d2fe1ee3b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 9, 2018 - [483 - Pharmaceutics International, Inc. - 2017-10-27](https://www.keypedia.com/records/483/pharmaceutics-international-inc/1072b5e6-ef5e-404d-a0b3-54063b982137) — source: FDA, date: October 27, 2017 - [FDA Inspection 1030024 - Pharmaceutics International, Inc. - 2017-10-27](https://www.keypedia.com/records/fda_inspections/pharmaceutics-international-inc/210de1ab-41c0-407d-a223-367de4d1e793) — classification: Official Action Indicated (OAI), source: FDA, date: October 27, 2017 - [483 - Pharmaceutics International, Inc. - 2016-04-04](https://www.keypedia.com/records/483/pharmaceutics-international-inc/6fb09bb0-c571-4f95-9373-92e75ada3ab8) — source: FDA, date: April 4, 2016 ## Related Companies - [Fresenius Kabi USA LLC](https://www.keypedia.com/companies/fresenius-kabi-usa-llc/f694c817-29ea-47cf-b819-8cf11fbfc4da) - [Catalent Pharma Solutions, LLC](https://www.keypedia.com/companies/catalent-pharma-solutions-llc/d29a124f-fdcb-4108-9eac-661149b4d20e) - [Sun Pharmaceutical Industries Ltd.](https://www.keypedia.com/companies/sun-pharmaceutical-industries-ltd/0ee9565e-1ff7-4ffa-b6ad-c38bccdc32e6) - [Unilever Manufacturing (US), Inc.](https://www.keypedia.com/companies/unilever-manufacturing-us-inc/ae587d51-1cf8-4ced-af22-8da0d2758cf6) - [Pyramid Laboratories, Inc.](https://www.keypedia.com/companies/pyramid-laboratories-inc/28e777be-a530-400a-97c6-9780ede4fb33) - [Apertus Pharmaceuticals](https://www.keypedia.com/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155) - [BRS Analytical Services, LLC](https://www.keypedia.com/companies/brs-analytical-services-llc/841b237e-76fe-4854-a862-802339b3e528) - [COSMETIC LABORATORY INC](https://www.keypedia.com/companies/cosmetic-laboratory-inc/f3977335-f446-489a-be98-aa03c573776b) - [Lilly del Caribe, Inc](https://www.keypedia.com/companies/lilly-del-caribe-inc/5091d4cf-a496-46ba-96aa-da9dbb686073) - [Eisai Company Ltd.](https://www.keypedia.com/companies/eisai-company-ltd/3b8d9042-088d-4b84-9382-fcdcfd5ef360) ## Related Officers - [Investigator](https://www.keypedia.com/people/erik-w-koester/2bbab081-6783-40a1-83c1-b219bde22bd1) - [Vivin George](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148) - [Investigator](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a) - [FDA Biologics Investigator](https://www.keypedia.com/people/viviana-matta/6fecf0ca-0edc-4538-a57e-72642f41b5c7) - [Robert J. Martin](https://www.keypedia.com/people/robert-j-martin/8bd5c75a-ec53-4ae5-9739-a39489686cae) - [Investigator](https://www.keypedia.com/people/edmund-f-mrak/a43cf86a-c020-4948-bff6-358b2453908a)